Refractory and relapsing forms of Clostridium difficile-associated colitis
Abstract
The aim of review. To discuss the factors promoting development of refractory and relapsing forms of colitis, associated to Clostridium difficile infection, to present the state-of-the-art in management of patients with these variants of the course of disease.
Original positions. Relapsing forms of the Clostridium difficile-associated colitis, are seen in 15– 30% of patients. Their development is promoted by elderly age of patients, significant duration of diarrhea at the first relapse, intake of proton pump inhibitors. In treatment of such patients courses of vancomycine and metronidazole, supplemented by probiotics (Sacharomyces boulardi), adsorbents (Colestyraminum, smecta) and rifaximin are applied.
Conclusion. The problem of refractory and relapsing forms of Clostridium difficile-associated colitis, requires the further studying to increase treatment efficacy.
References
1. Barlett J.C. Pseudomembranous enterocolitis and antibiotic-associated diarrhea // Sleisenger and Fordtran’s gastrointestinal and liver disease / Ed. M. Feldman et al.– 7th ed. – Philadelphia–London–Toronto–Montreal– Sydney–Tokyo, 2002. – P. 1914–1931.
2. Bauer T. Darminfektionen (Clostridium difficile, Norovirus) // XIII Gastroenterologie-Seminarwoche Titisee. – Freiburg, 2010. – S. 235–238.
3. Dalton B.R., Lye-Maccannell T., Henderson E.A. et al. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, nonoutbreak hospital setting // Aliment. Pharmacol. Ther.– 2009. – Vol. 29. – P. 626–634.
4. Johnson S., Schriever Ch., Galang M. Interruption of recurrent Clostridium difficile associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Brief report // CID. – 2007. – Vol. 44. – P. 1–3.
5. Jumaa P., Wren B., Tabaqchali S. Epidemiology and typing of Clostridium difficile // Eur. J. Gastroenterol. Hepatol. – 1996. – Vol. 8. – P. 1035–1040.
6. Jung K.S., Cheon J.H., Park J.J. et al. Risk factors of treatment failure and relapse after metronidazole or vancomycin treatment for Clostridium difficileassociated diarrhea: a 10-year study in a single tertiare center in Korrea // Gut. – 2009. – Vol. 58 (suppl. II). – P. 406.
7. Kassam Z., Rajveer H., Marshall K., Lee Ch.H. Fecal transplantation via retention enema is effective for recurrent or refractory Clostridium difficile associated diarrhea // DDW – New Orleans. – 2010. – Abstract.– P. 1223.
8. Kim Y.G., Jang B-I, Choi E.J. et al. Association of proton pump inhibitors with recurrent Clostridium difficile associated disease: a matched case-control analysis by using propensity score // DDW – New Orleans. – 2010.– Abstract. – P. 1231.
9. Koro N., Abdalla Y., Kanwal F. et al. Risk factors for recurrent Clostridium difficile-associated diarrhea: a retrospective case-control study // DDW – New Orleans. – 2010. – Abstract. – P. 1229.
10. McFarland L.V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease // Am. J. Gastroenterol. – 2006. – Vol. 101. – P. 812–822.
11. Morga M., Barr M., Mercogliano G., Kuntz C. Proton pump inhibitors increase risk of severe disease among patients hospitalized with Clostridium difficile associated diarrhea // DDW – New Orleans. – 2010. – Abstract.– P. 1225.
12. Naegals S., Ruytjens I., Terriere L. et al. Fecal transplantation for recurrent Clostridium difficile colitis, an underused treatment modality // Gut. – 2009. – Vol. 58 (suppl. II). – P. 407.
13. Pothoulakis Ch. Pathogenesis of Clostridium difficileassociated diarrhea // Eur. J. Gastoenterol. Hepatol. – 1996. – Vol. 8. – P. 1041–1047.
14. Rodermann J.R., Dubberke E.R., Reske K.A. et al.
15. Incidence of Clostridium difficile infection in inflammatory bowel disease // Clin. Gastroenterol. Hepatol. – 2007. – Vol. 5. – P. 339–344.
16. Shukla S., Shukla A., Guha S., Mehboob Sh. Use of proton pump inhibitors and risk of Clostridium difficileassociated diarrhea: a meta-analysis // DDW – New Orleans. – 2010. – Abstract. – P. 1230
17. Surawicz Ch.M. Refractory and recurrent C. difficile colitis: what are the latest treatment options and what works // AGA spring postgraduate course. – New Orleans, 2010. – P. 153–176.
18. Zar F. et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity // Clin. Infect. Dis. – 2007. – Vol. 45. – P. 302–307.
Review
For citations:
Sheptulin A.A. Refractory and relapsing forms of Clostridium difficile-associated colitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2011;21(2):50-53. (In Russ.)
Views:
130
Email this article 
